Cytheris Raises €12 Million

Cytheris SA, a French drug startup focused on immune modulation, has raised €12 million in Series D funding. CDC Entreprises led the round, and was joined by return backers Gestion, Caisse de dépôt et Placement du Québec, CDC Innovation, Crédit Agricole Private Equity and Forbion Capital Partners.

North AmericaUSBriefs